{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:56:05Z","timestamp":1792058165149,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T00:00:00Z","timestamp":1285286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Many patients with Wegener's granulomatosis (WG) have anti-neutrophil cytoplasmic antibodies (c-ANCA). Aside from being a diagnostic marker, these autoantibodies may play roles in disease pathogenesis. Proteinase 3 (PR3) is the primary target of c-ANCA in WG patient sera. Of 60 c-ANCA-positive patients, 10 patients were selected for detailed humoral epitope analysis, contingent upon serum availability, using samples with positive levels of anti-PR3 by enzyme-linked immunosorbent assay (ELISA). Sequential epitope specificities of anti-PR3 antibodies detected by screening the maximally overlapping solid-phase octapeptides of PR3 showed seven major common antigenic targets bound by WG patient sera. These include novel and previously identified sequential PR3 epitopes bound by c-ANCA. B cell epitope prediction algorithms identified all or part of the seven defined epitopes. Several epitopes share sequence and structural proximity with functional sites, including the catalytic triad and proposed binding sites of other potential proteins [PR3 complementary peptide and soluble endothelial protein C receptor (sEPCR)]. Epitope 4 (VVLGAHNVRTQ) had the highest binding prevalence (90%) and epitope 2 (AQPHSRPYMAS) has the highest average reactivity of the antigenic regions. Epitope 4 includes the interaction site between sEPCR and PR3 which may serve as an important interaction to down-regulate inflammation. Epitopes 3, 5 and 7 are in direct proximity to amino acids that form the catalytic triad of the protein. c-ANCA targets both unique and previously known sequential PR3 peptides. This information may prove useful in understanding anti-PR3-mediated disease pathogenesis in systemic vasculitides.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04251.x","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T11:31:32Z","timestamp":1285327892000},"page":"262-270","source":"Crossref","is-referenced-by-count":15,"title":["Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener's granulomatosis"],"prefix":"10.1093","volume":"162","author":[{"given":"B F","family":"Bruner","sequence":"first","affiliation":[{"name":"Oklahoma Medical Research Foundation"},{"name":"University of Oklahoma Health Sciences Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Vista","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Wynn","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation"},{"name":"University of Oklahoma Health Sciences Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Harley","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation"},{"name":"University of Oklahoma Health Sciences Center"},{"name":"Veteran's Affairs Medical Center, Oklahoma City, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"James","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation"},{"name":"University of Oklahoma Health Sciences Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,24]]},"reference":[{"key":"2021122708483842900_b1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis","volume":"111","author":"Nolle","year":"1989","journal-title":"Ann Intern Med"},{"key":"2021122708483842900_b2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/BOR.0b013e3280119842","article-title":"Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis","volume":"19","author":"Kallenberg","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708483842900_b3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2021122708483842900_b4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int"},{"key":"2021122708483842900_b5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2021122708483842900_b6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ndt\/16.8.1631","article-title":"ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis","volume":"16","author":"Nowack","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708483842900_b7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"2021122708483842900_b8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.1994.tb06519.x","article-title":"Anti-proteinase 3 antibodies, their characterization and disease associations","volume":"95","author":"Jennings","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/art.24576","article-title":"Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes","volume":"60","author":"Berden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021122708483842900_b10","doi-asserted-by":"crossref","first-page":"35976","DOI":"10.1074\/jbc.M806754200","article-title":"A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors","volume":"283","author":"Korkmaz","year":"2008","journal-title":"J Biol Chem"},{"key":"2021122708483842900_b11","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1097\/01.ASN.0000034911.03334.C3","article-title":"Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways","volume":"13","author":"Preston","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2021122708483842900_b12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"2021122708483842900_b13","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.165.8.4697","article-title":"The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b\/CD18","volume":"165","author":"Kurosawa","year":"2000","journal-title":"J Immunol"},{"key":"2021122708483842900_b14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI119548","article-title":"Identification of functional endothelial protein C receptor in human plasma","volume":"100","author":"Kurosawa","year":"1997","journal-title":"J Clin Invest"},{"key":"2021122708483842900_b15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1797.2008.01076.x","article-title":"Review article: leukocyte\u2013endothelial dysregulation in systemic small vessel vasculitis","volume":"14","author":"Pankhurst","year":"2009","journal-title":"Nephrology"},{"key":"2021122708483842900_b16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"Van Der Woude","year":"1985","journal-title":"Lancet"},{"key":"2021122708483842900_b17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01926.x","article-title":"Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis","volume":"129","author":"Van Der Geld","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.1993.tb08192.x","article-title":"Relevance of classic anti-neutrophil cytoplasmic autoantibody (c-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis","volume":"93","author":"Dolman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/art.24442","article-title":"Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils","volume":"60","author":"Hu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021122708483842900_b20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.172.6.1709","article-title":"Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils","volume":"172","author":"Campanelli","year":"1990","journal-title":"J Exp Med"},{"key":"2021122708483842900_b21","doi-asserted-by":"crossref","first-page":"21193","DOI":"10.1016\/S0021-9258(19)36816-4","article-title":"Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen","volume":"267","author":"Sturrock","year":"1992","journal-title":"J Biol Chem"},{"key":"2021122708483842900_b22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(89)90752-6","article-title":"Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells","volume":"59","author":"Bories","year":"1989","journal-title":"Cell"},{"key":"2021122708483842900_b23","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.156.10.4018","article-title":"Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns","volume":"156","author":"James","year":"1996","journal-title":"J Immunol"},{"key":"2021122708483842900_b24","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.168.4.2054","article-title":"Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens","volume":"168","author":"McClain","year":"2002","journal-title":"J Immunol"},{"key":"2021122708483842900_b25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2249.1994.tb05507.x","article-title":"Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr\/lpr antibodies","volume":"98","author":"James","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jmbi.1996.0458","article-title":"The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies","volume":"261","author":"Fujinaga","year":"1996","journal-title":"J Mol Biol"},{"key":"2021122708483842900_b27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10822-005-9027-x","article-title":"BALL view: an object-oriented molecular visualization and modeling framework","volume":"19","author":"Moll","year":"2005","journal-title":"J Comput Aided Mol Des"},{"key":"2021122708483842900_b28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res"},{"key":"2021122708483842900_b29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2021122708483842900_b30","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.4049\/jimmunol.152.9.4722","article-title":"Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis","volume":"152","author":"Williams","year":"1994","journal-title":"J Immunol"},{"key":"2021122708483842900_b31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2249.2001.01420.x","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site","volume":"123","author":"Griffith","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1523-1755.2001.00475.x","article-title":"Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides","volume":"59","author":"Van Der Geld","year":"2001","journal-title":"Kidney Int"},{"key":"2021122708483842900_b33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2249.2004.02572.x","article-title":"B cell epitope specificity in ANCA-associated vasculitis: does it matter?","volume":"137","author":"Van Der Geld","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1398.010","article-title":"Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses","volume":"1109","author":"M\u00fcller","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2021122708483842900_b35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V99.2.526","article-title":"Plasma levels of endothelial protein C receptor respond to anticoagulant treatment","volume":"99","author":"Stearns-Kurosawa","year":"2002","journal-title":"Blood"},{"key":"2021122708483842900_b36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2002.01803.x","article-title":"Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis","volume":"128","author":"Boomsma","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122708483842900_b37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrneph.2009.51","article-title":"Vasculitis syndromes: LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis","volume":"5","author":"Bosch","year":"2009","journal-title":"Nat Rev Nephrol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/2\/262\/41924554\/j.1365-2249.2010.04251.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/2\/262\/41924554\/j.1365-2249.2010.04251.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T13:29:26Z","timestamp":1685798966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/162\/2\/262\/6438637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,24]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,9,24]]},"published-print":{"date-parts":[[2010,10,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04251.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,11]]},"published":{"date-parts":[[2010,9,24]]}}}